Third, the present study relied solely on peripheral blood parameters to calculate PIV and did not incorporate tissue-based immune characteristics, such as tumor-infiltrating lymphocytes (TILs), CD8+ T-cell density, or PD-L1 expression, which could further substantiate the biological relevance of systemic inflammatory status in TNBC. This evidence concerns the gene CD8A and neoplasm.